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go a series of staged reconstructive procedures leading
to an eventual Fontan operation. The short- and long-
term outcomes for these children have improved signif-
icantly in recent years. Improvements in surgical tech-
niques and perioperative management have contributed
to significant decreases in mortality and morbidity after
the Fontan procedure. Certain anatomic factors, however,
including HLHS, heterotaxy syndrome, and total anom-
alous pulmonary venous connection (TAPVC), have
been associated with increased early and late mortality
after the Fontan procedure. The current study was
undertaken to assess the impact of TAPVC on early
mortality and long-term outcome in children with func-
tional single ventricle.
Methods
All patients with functional single ventricle and TAPVC
treated at The Children’s Hospital of Philadelphia between
July l, 1984, and December l, 1997, were eligible for entry
T he term functional single ventricle encompasses aheterogeneous group of anomalies including
hypoplastic left heart syndrome (HLHS), tricuspid atre-
sia, heterotaxy syndrome, and other complex cardiac
defects. Many children with these anomalies are
referred for treatment in the neonatal period and under-
Background and methods: Between January 1, 1984, and December 1,
1997, 73 infants with functional single ventricle and total anomalous
pulmonary venous connection were admitted to our institution. A retro-
spective review was undertaken to determine factors influencing sur-
vival. Results: Heterotaxy syndrome was present in 52 patients and
hypoplastic left heart syndrome in 14. Obstructed total anomalous pul-
monary venous connection was present in 21 patients. The pulmonary
venous connection was supracardiac in 32 patients, cardiac in 21
patients, infracardiac in 13, and mixed in 7. Twelve patients died before
the operation. The remaining 61 patients underwent surgery at a medi-
an age of 5 days (range 1 day–2.5 years). Overall survival was 45% at 6
months of age, 37% at 1 year, and 19% at 5 years. Survival for patients
undergoing surgery was 54% at 6 months of age, 44% at 1 year, and
23% at 5 years. By univariate analysis with the Cox proportional haz-
ards model, younger age at the time of the initial operation and repair
of total anomalous pulmonary venous connection were predictors of
mortality. Lung tissue from 14 patients was available for histologic
examination. The pulmonary veins were dilated and wall thickness was
increased. Increased muscularization of the arteries was seen in 11
patients. Conclusions: The long-term prognosis for children undergoing
staged reconstructive operations for single ventricle and total anom-
alous pulmonary venous connection is poor. Early mortality is high and
late death is a continuing risk. Development of the pulmonary vascula-
ture, especially the pulmonary veins, is abnormal, even in children with-
out clinical evidence of pulmonary venous obstruction. (J Thorac
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into the study. Patients were retrospectively identified by
review of the cardiac surgical and echocardiography databases,
as well as autopsy records. The medical records were
reviewed and follow-up information was obtained from med-
ical records and contact with referring physicians.
Data are presented as mean ± standard deviation or median
as appropriate. Variables were compared by means of the
Student unpaired t test. Confidence levels (95%) are present-
ed as appropriate. For survival analysis, date of birth was
taken as zero time. The patients were censored at the time of
death or were withdrawn alive at the time of last follow-up
contact. The Kaplan-Meier survival estimates with 95% con-
fidence limits are provided. Survival distributions between
groups were compared by means of the log rank test. The
Cox proportional hazards model was used to examine the
effects of anatomic and procedural variables on survival time
both in the entire population (n = 73) and in the subgroup
who underwent surgery (n = 61) (see Table III). A univariable
analysis was performed and variables with P < .1 were
included in the multivariable analysis. Data analysis was per-
formed by means of SPSS version 7.5.1 (SPSS, Inc, Chicago,
Ill) and SAS version 6.12 (SAS Institute, Inc, Cary, NC).
Results
Between July 1, 1984, and December 31, 1997, 73
children (40 boys and 33 girls) with functional single
ventricle and TAPVC were admitted to The Children’s
Hospital of Philadelphia. Seven of these children were
born before 1984. The patients were classified into 3
groups according to diagnosis (Table I). Heterotaxy
syndrome was present in 52 children (group I); 41
patients had asplenia, 9 had polysplenia, and 2 had nor-
mal spleens. Splenic anatomy was confirmed by autop-
sy or other tests in 23 patients. HLHS was present in 14
patients (group II). Seven patients with other forms of
Table I
No. of patients
Group I: Heterotaxy (n = 52)
Asplenia (n = 41)
Unbalanced CAVC 41
DORV 29
Outflow tract obstruction
Pulmonary 34 
(pulmonary atresia, n = 19)
Systemic 5
None 2
Biventricular 0
Pulmonary venous connection
Supracardiac 17
Cardiac 9
Infracardiac 11
Mixed 4
Polysplenia (n = 9)
Unbalanced CAVC 8
DORV 3
Outflow tract obstruction
Pulmonary 4 
(pulmonary atresia, n = 1)
Systemic 4
None 0
Biventricular 1
Pulmonary venous connection
Supracardiac 1
Cardiac 8
Infracardiac 0
Mixed 0
Normal spleen (n = 2)
Both DORV/unbalanced CAVC 2
Pulmonary stenosis 1
Pulmonary atresia 1
Pulmonary venous connection
Supracardiac 0
Cardiac 1
Infracardiac 0
Mixed 1
Group II: HLHS (n = 14)
Aortic atresia or stenosis/mitral atresia 11
DORV/aortic atresia or stenosis/mitral atresia 3
Pulmonary venous connection
Supracardiac 11
Cardiac 2
Infracardiac 1
Mixed 0
Group III: Other (n = 7)
DORV/mitral atresia/no outflow tract obstruction 2
DORV/mitral atresia/pulmonary atresia or stenosis 2
Tricuspid atresia/pulmonary atresia or stenosis 2
DORV/hypoplastic LV/pulmonary atresia 1
Pulmonary venous connection
Supracardiac 3
Cardiac 1
Infracardiac 1
Mixed 2
CAVC, Common atrioventricular canal; DORV, double-outlet right ventricle;
LV, left ventricle.
Table II. Initial palliation
Procedure Early mortality
Aortopulmonary shunt 11% (2/18)
Aortopulmonary shunt with TAPVC repair 83% (10/12)
Norwood procedure 67% (4/6)
Norwood procedure with TAPVC repair 46% (6/13)
Other procedures 42% (5/12)
Superior cavopulmonary connection (n = 4)
Superior cavopulmonary connection with 
TAPVC repair (n = 1)
Pulmonary artery band with TAPVC repair 
(n = 2)
Pulmonary valvotomy with TAPVC repair 
(n = 1)
TAPVC repair (n = 2)
Modified Fontan procedure (n = 1)
Atrioventricular valve annuloplasty (n = 1)
TAPVC, Total anomalous pulmonary venous connection.
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single ventricle were classified as group III. The pul-
monary venous connection was supracardiac in 32
patients, cardiac in 21 patients, infracardiac in 13, and
mixed in the remaining 7. Obstructed pulmonary
venous drainage was diagnosed clinically in 21
patients. Obstructed TAPVC was present in 14 group I
patients (27%), 4 group II patients (29%), and 3 group
III patients (43%). Obstruction to pulmonary blood
flow was present in 45 patients and obstruction to sys-
temic blood flow in 23 patients. Biventricular outflow
tract obstruction was present in 1 patient, and 4 had no
outflow tract obstruction. Pulmonary atresia was pre-
sent in 23 patients. Either systemic or pulmonary blood
flow was dependent on ductal patency in 49 patients.
Twelve patients died before palliative surgery.
Reconstructive surgery was performed in 61 patients
(Table II). Seven patients underwent surgery at other
institutions. Six patients underwent initial placement of
systemic-pulmonary shunts at other institutions. One
patient underwent a bidirectional Glenn shunt at anoth-
er institution after an initial shunt at The Children’s
Hospital of Philadelphia. These patients are included in
the analysis. The median age at the time of initial pal-
liation was 5 days (range 1 day–2.5 years). Forty
patients underwent surgical intervention in the first
week of life and 44 underwent surgical intervention in
the first 30 days of life. Overall early mortality (death
within 30 days of the initial operation or before hospi-
tal discharge) was 53% (39/73). For patients undergo-
ing surgery, the early mortality was 44% (27/61). Initial
palliation included aortopulmonary shunt in 18
patients, aortopulmonary shunt with TAPVC repair in
12, Norwood procedure in 6, Norwood procedure with
TAPVC repair in 13, and other procedures in 12 (Table
II). Early mortality for group I was 44% (18/41), group
II 50% (7/14), and group III 33% (2/6). Repair of
TAPVC, either alone or in association with other pro-
cedures, was performed during the initial operation in
31 patients. The early mortality for these patients was
higher than that for the patients not undergoing TAPVC
repair: 58% (18/31) versus 30% (9/30); P = .03.
TAPVC was repaired in 17 of 41 patients in group I, 11
of 14 patients in group II, and 3 of 6 patients in group
III. Three patients underwent repair of supracardiac
TAPVC at a later operation and only 1 is a long-term
survivor. The highest early mortality was in patients
undergoing aortopulmonary shunt in combination with
TAPVC repair (83%).
Thirty-two patients underwent a superior cavopul-
monary connection (hemi-Fontan or bidirectional Glenn
shunt) or a modified Fontan procedure, or both. Before
the superior cavopulmonary connection, the mean pul-
monary artery pressure was 15 ± 4 mm Hg with a
transpulmonary gradient of 10 ± 4 mm Hg (n = 12). The
arterial oxygen saturation was 77% ± 5%. Pulmonary
artery pressure was not measured in all patients and 2
patients were excluded. One patient had undergone a
Waterston shunt and had nearly discontinuous pul-
monary arteries. The other patient had pulmonary
venous obstruction as a result of anastomotic narrowing.
Before the modified Fontan procedure, the pulmonary
artery pressure was 14 ± 5 mm Hg with a transpul-
monary gradient of 7 ± 6 mm Hg (n = 16). The arterial
oxygen saturation was 79% ± 7%. Twenty-one patients
underwent superior cavopulmonary connection with an
early mortality of 38% (8/21). In 5 of these patients,
superior cavopulmonary connection was performed as
the initial procedure, with 2 early deaths. Nineteen
patients underwent a modified Fontan procedure, 8 of
whom had previously undergone a superior cavopul-
monary shunt. One patient underwent the modified
Fontan procedure as initial palliation. The early mortali-
ty was 42% (8/19). In 1 patient, the modified Fontan
shunt was reduced to a superior cavopulmonary connec-
tion in the operating room and this patient died. There
have been 2 late deaths after the Fontan procedure.
Recurrent pulmonary venous obstruction necessitat-
ing reoperation developed in 7 of the 13 survivors
(54%) of initial TAPVC repair. Only 1 of these patients
is a long-term survivor. Infracardiac TAPVC was pre-
sent in 5 of these patients and supracardiac TAPVC in
2. Pulmonary venous obstruction had been present in 3
of the patients before the initial TAPVC repair.
Follow-up is complete (death or December 1, 1997)
in 71 of the 73 patients (97%). In the 2 remaining
patients, partial follow-up was available until their fam-
ilies moved abroad (11 months and 15 years after the
Table III. Variables for Cox proportional hazards
model
Patients undergoing surgery 
Entire population (n = 73) (n = 61)
Surgery Age at initial operation
Obstructed TAPVC TAPVC repair
Type of TAPVC Ductus dependent
Ductus dependent Obstructed TAPVC
Type of outflow obstruction Type TAPVC
HLHS HLHS
Heterotaxy syndrome Heterotaxy syndrome
Norwood procedure
Recurrent pulmonary venous 
obstruction
TAPVC, Total anomalous pulmonary venous connection; HLHS, hypoplastic
left heart syndrome. 
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operation). As of December 1, 1997, 12 of the 73
patients were alive and 9 of these patients had success-
fully undergone the modified Fontan procedure. The
median duration of follow-up for the entire group (n =
73) is 4 months (range 1 day–17 years). The median
follow-up for patients who survived the initial hospital-
ization (n = 34) is 26 months (range 0.1 month–17
years). Fifty-one patients were followed up for at least
6 months, 25 for 1 year, 18 for 2 years, and 11 patients
for more than 5 years. For the entire group (n = 73),
survival was 45% (95% CL, 34%, 57%) at 6 months,
37% (95% CL 25%, 48%) at 1 year, and 19% (95% CL
10%, 29%) at 5 years. Survival was better for the
patients who underwent surgery: 54% (95% CL 42%,
67%) at 6 months, 44% (95% CL 31%, 56%) at 1 year,
and 23% (95% CL 12%, 34%) at 5 years, P < .0001 by
log rank test (Fig 1). For the entire group, survival was
worse for patients with obstructed TAPVC than for
those with unobstructed TAPVC (P = .02). Repair of
TAPVC at the initial operation was associated with
worse survival (P = .02) (Fig 2).
The Cox proportional hazards model was used to
assess the effect of anatomic and procedural variables
on survival time (Table IV). For the entire group (n =
73), palliative surgery was associated with improved
survival with a risk ratio of 0.204 (P = .0001).
Obstructed pulmonary venous drainage was associated
with a poorer survival, with a risk ratio of 1.864 (P =
.02). For the subgroup of patients who underwent
surgery (n = 61), repair of TAPVC and younger age at
the time of the initial operation were associated with
decreased survival time in the univariable analysis. For
the entire group (n = 73), multivariable analysis showed
only palliative surgery to be associated with improved
survival. Obstructed drainage was present in 5 of 12
children (42%) who died before having an operation,
compared with 16 of the 61 patients (26%) who did
have an operation. In the multivariable analysis, only
younger age remained significant.
Pulmonary tissue for histologic examination of the
vasculature was available from autopsy for 14 patients
(median age at death 23 days, range 2 days–8.8
months). Heterotaxy syndrome was present in 7
patients. The pulmonary venous connection was
supracardiac in 8, infracardiac in 4, and mixed in 2.
Clinical evidence of obstruction of pulmonary venous
drainage was present in only 5 patients. Obstruction to
pulmonary blood flow was present in 8 patients (4 with
pulmonary atresia) and obstruction to systemic blood
flow in 5. The remaining patient had no outflow tract
obstruction. Palliative operations were performed in 12
of these patients and TAPVC repair in 10. In all 14
patients, the pulmonary veins were markedly dilated
with increased wall thickness for age (Fig 3). Elastic
tissue staining demonstrates multiple elastic laminae in
the vein wall consistent with “arterialization” of the
pulmonary veins, which is not seen in patients with
normal pulmonary venous connection (Fig 4).
Increased muscularization of the pulmonary arteries
was present in 11 patients.
Discussion
The short- and long-term outcomes for children with
functional single ventricle including HLHS have
improved markedly in recent years.1,2 Since the intro-
duction of the Fontan procedure in the early 1970s,
modifications of surgical techniques, improved patient
selection, and improved perioperative management
have resulted in significant decreases in both early and
late mortality. The use of staged reconstruction in
Table IV. Cox proportional hazards model
Regression 
Variable coefficient b SE P Risk ratio 95% CL
Univariable analysis
Entire group (n = 73)
Palliative surgery –1.588 0.372 .0001 0.204 (0.098, 0.424)
Obstructed TAPVC .623 0.277 .02 1.864 (1.083, 3.210)
Patients undergoing surgery (n = 61)
Repair of TAPVC .698 0.296 .02 2.009 (1.125, 3.587)
Age at initial operation –.004 0.002 .02 0.996 (0.993, 0.999)
Multivariable analysis
Entire group (n = 73)
Palliative operation –1.506 0.373 .0001 0.222 (0.107, 0.460)
Patients undergoing surgery (n = 61)
Age at initial operation –.003 0.002 .04 0.997 (0.994, 1.000)
SE, Standard error; CL, confidence limits; TAPVC, total anomalous pulmonary venous connection.
510 Gaynor et al The Journal of Thoracic and
Cardiovascular Surgery
March 1999
which a superior cavopulmonary connection is con-
structed before the completion of the Fontan procedure
has further reduced early mortality and morbidity.1 The
early and long-term outcomes after surgical repair of
isolated TAPVC are excellent.3 Previous reports, how-
ever, have suggested that the association of TAPVC
with single ventricle, particularly in patients with het-
erotaxy syndrome, is a risk factor for poor outcome.4-8
The current study was undertaken to assess the impact
of TAPVC on early mortality and long-term outcome in
infants with single ventricle. Heterotaxy syndrome was
present in the majority of these children. This study
demonstrates that the long-term prognosis for these chil-
dren is poor. Palliative surgery resulted in improved sur-
vival; however, the mortality for the initial palliative pro-
cedure is high, and late death is a continuing risk.
Mortality rates at the time of superior cavopulmonary
connection and the Fontan operation were much greater
than for children without TAPVC.1 The cause of death
often could not be determined from the medical record;
however, in the majority of cases significant hypoxemia
and inadequate cardiac output were evident. Obstruction
to pulmonary venous drainage was a risk factor for mor-
tality for the entire group. Younger age at the time of the
initial operation and repair of TAPVC were associated
with increased mortality. Early and late mortality were
significantly greater in patients who underwent repair of
TAPVC. Recurrent pulmonary venous obstruction was
prevalent after TAPVC repair (>50%). Only 1 patient
with recurrent pulmonary venous obstruction is a long-
term survivor. The reasons for the increased incidence of
recurrent pulmonary venous obstruction are unclear.
Histologic examination of lung tissue from patients in
this series demonstrates that development of the pul-
monary vasculature, particularly the pulmonary veins, is
abnormal in infants with single ventricle and TAPVC.
The veins were abnormal even in the absence of clinical
evidence of pulmonary venous obstruction, suggesting
that current diagnostic techniques may underestimate the
severity of obstruction.
Fig 1. Actuarial survival (Kaplan-Meier) comparing outcome for all patients with outcome of those undergoing
staged reconstructive operations.
Fig 2. Actuarial survival (Kaplan-Meier) comparing outcome for patients who underwent TAPVC repair with out-
come for those in whom TAPVC repair was not performed.
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DeLeon and colleagues4 reported early results after
palliative surgery in 8 infants with obstruction to pul-
monary blood flow and TAPVC. Heterotaxy syndrome
was present in all patients and 7 patients had function-
al single ventricle. Four of these 7 patients died. Di
Donato and colleagues5 reported outcome after pallia-
tion in 14 children with right atrial isomerism (asple-
nia) and TAPVC. Thirteen patients underwent pallia-
tive operations consisting of aortopulmonary shunts in
10 patients and shunts with TAPVC repair in 3 patients.
There were 7 hospital deaths (54%) and 2 late deaths.
No patients had undergone cavopulmonary connection
or a Fontan procedure at the time of these reports.
Heinemann and associates6 reported their experience
with initial palliation in 21 patients with heterotaxy
syndrome and TAPVC. Pulmonary venous drainage
was obstructed in 12 patients and unobstructed in 9.
None of these patients had obstruction to systemic
blood flow. The overall early mortality was 28.6%
(6/21). The mortality for aortopulmonary shunt alone
was 25% (2/8) and for shunt in combination with
TAPVC repair, 33.3% (2/6). Mortality for TAPVC
repair alone was 50% (2/4). Long-term follow-up was
not reported.
Sadiq and coworkers7 recently reported outcomes
after surgical palliation of 20 children with right atrial
isomerism. TAPVC was present in 16 patients. The
overall mortality was 55% (11/20) and was 82% (9/11)
in patients who underwent surgery during the first
month after birth. Seven patients have undergone the
Fig 3. A, A pulmonary vein from a patient with HLHS and
normal venous return appears in the center of the photograph
as a dilated vessel without markedly thickened media; a dilat-
ed lymphatic vessel is at the right of the vein in the interlob-
ular septum. B, A very abnormal pulmonary vein from a
study patient is seen in the interlobular septum, surrounded
by alveolar spaces. The vein wall is very thick and nuclei are
seen in the mural fibers. (A and B, Hematoxylin and eosin
stain; original magnifications · 400.)
A
B
Fig 4. A, An elastic tissue stain of a pulmonary vein of the
same patient as in Fig 3, A, shows a thin wall, without dis-
tinct inner and outer elastic tissue laminae. B, In contrast, an
elastic tissue stain from a vein of the same patient as in Fig 3,
B, shows multiple elastic tissue laminae, so-called arterial-
ization of the venous wall. (A and B, Elastic van Gieson
stain; original magnifications · 400.)
A
B
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Fontan procedure, with 2 deaths. No patient who was
referred to us during the first week of life with obstruct-
ed TAPVC and pulmonary atresia survived.
Hashmi and associates8 reported outcomes for 91
patients with right atrial isomerism treated at The
Hospital for Sick Children in Toronto between 1970
and 1996. Surgery was undertaken in 69 patients, and
64 of these underwent staged reconstructive surgery
with the plan of an eventual Fontan procedure. TAPVC
repair alone or in association with other procedures
was performed in 20 children with an early mortality of
95%. At last follow-up, 40 of the 64 patients had died,
10 had successfully undergone the Fontan procedure,
13 were alive and awaiting the Fontan procedure, and 1
patient had undergone cardiac transplantation. Overall
actuarial survival was 49% at 1 year and 35% at 5
years. Risk factors for mortality were absence of pul-
monary outflow obstruction, presence of major atri-
oventricular valve anomaly, and obstructed TAPVC.
Alejos and colleagues9 evaluated risk factors for
mortality in 129 patients undergoing bidirectional
Glenn shunts. Anomalous pulmonary venous connec-
tion, either partial or total, and heterotaxy syndrome
were risk factors for death. McElhinney and col-
leagues10 reported outcome after bidirectional Glenn
shunts in patients with anomalies of systemic and pul-
monary venous drainage. In this series, 11 patients had
single ventricle and TAPVC. Heterotaxy syndrome was
present in 10 of the 11 patients. Repair of TAPVC was
necessary in only 3 patients. One early death and 1 late
death occurred among the 11 patients.
Razzouk and associates11 reported outcomes after
cardiac transplantation in 12 children with complex
cardiac defects and TAPVC. Heterotaxy syndrome was
present in 9 patients and HLHS in 2. TAPVC was
supracardiac in 10, infracardiac in 1, and mixed in 1.
Six children had undergone a previous operation, but
only 1 had undergone TAPVC repair. Transplantation
was performed during the first 6 months after birth in 8
of the 12 patients. Overall survival was excellent, with
only 1 early and 1 late death. Recurrent pulmonary
venous obstruction developed in 2 patients. A more
recent report of transplantation in 20 patients with het-
erotaxy syndrome (13 with TAPVC) demonstrated a 1-
year survival of 93% and a 5-year survival of 65%.12
The findings of the current study are consistent with
those of previously published results and demonstrate a
significant early mortality and poor long-term outcome
for children with functional single ventricle and
TAPVC. Risk factors for mortality include younger age
at the time of the initial operation, obstructed TAPVC,
and need for TAPVC repair at the initial operation.
Children with more severe obstruction to pulmonary
venous drainage are likely to have more severe changes
in the pulmonary vasculature and to be referred for
treatment at an earlier age. The greatest risk for early
death was in patients undergoing simultaneous creation
of an aortopulmonary shunt and TAPVC repair.
Interestingly, the presence of heterotaxy syndrome or
HLHS was not associated with worse outcomes.
Examination of the pulmonary vasculature from
patients with single ventricle and TAPVC reveals very
abnormal development, especially of the pulmonary
veins. It is likely that increased pulmonary vascular
resistance is a major cause of mortality for these chil-
dren. The cause of the increased mortality for superior
cavopulmonary connection and the Fontan procedure is
less clear. The preoperative hemodynamic data do not
suggest that the patients are at increased risk. However,
the pulmonary vascular abnormalities may contribute
to the increased mortality. Interestingly, despite the
abnormal pulmonary vasculature, the early results after
cardiac transplantation in these patients appear to be
satisfactory.11,12 Perhaps the pulmonary vascular
abnormalities are better tolerated when a ventricle pro-
vides pulmonary blood flow rather than an arterial or
venous shunt.
This study has several limitations. It is retrospective,
and the data are limited by review of the medical
records. To ensure inclusion of all patients, even those
who did not undergo surgery, we reviewed multiple
sources including the echocardiography database, sur-
gical database, and autopsy records. The criteria for
diagnosis of pulmonary venous obstruction were not
standardized. A patient was classified as having
obstructed TAPVC if the echocardiogram was consid-
ered to show obstruction of the draining vein or if the
physician caring for the patient diagnosed obstructed
venous drainage on the basis of the clinical course.
There is obviously some bias in the selection of
patients for histologic examination of the pulmonary
vasculature. Because only autopsy specimens were
available, the findings likely represent the more severely
affected patients.
In conclusion, this study demonstrates that children
with functional single ventricle and TAPVC have a very
poor prognosis. The outcome of staged reconstructive
surgery is poor. Alternative therapy such as cardiac
transplantation may be indicated for these patients.
We appreciate the contributions of the many physicians and
other personnel who cared for these patients, including Larry
W. Stephenson, MD, John D. Pigott, MD, William I.
Norwood, MD, and Marshall L. Jacobs, MD.
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Discussion
Dr William G. Williams (Toronto, Ontario, Canada). Dr
Gaynor’s review of infants with single ventricle and TAPVC
demonstrates the dismal outlook for these children despite the
authors’ best efforts. I congratulate them for their candor,
honesty, and courage in presenting this information.
Although better techniques in pediatric cardiac care have
produced substantially improved results for newborn infants
with either univentricular heart or TAPVC in isolation, the
combination of the two lesions appears to be almost univer-
sally fatal. 
First of all, I applaud their decision to include the babies
identified with the diagnosis but not surviving long enough to
undergo operation. The 16% who died before surgical inter-
vention are an index of the severity of these lesions. As sur-
geons, we do have an obligation to these patients who do not
survive long enough for our care. Our management protocols
must evolve to salvage these children. 
The most telling statistic is the failure to manage these
babies at the time of cavopulmonary shunt. The 38% mortali-
ty at cavopulmonary shunt, an operation which for other
lesions is a very low-risk procedure, is an index of the severi-
ty of the underlying disease that we do not clearly understand. 
The cavopulmonary shunt is used as a staging procedure in
patients with single ventricle to lessen the risk of a subse-
quent Fontan operation. In the authors’ series, only 26% of
the patients actually had a Fontan operation. This outcome is
very similar to our experience in patients with heterotaxy,
among whom only 22% eventually had the Fontan operation.
Cavopulmonary shunt was not apparently protective, as illus-
trated by the 42% operative risk at the time of the Fontan
operation and the subsequent 20% late mortality. 
In an analysis of cavopulmonary shunts in our center, it is
clear that there are some patients in whom conversion from a
cavopulmonary shunt to a Fontan circulation offers no sur-
vival advantage and is probably contraindicated. Patients
with heterotaxy, single ventricle, and TAPVC are good
examples of this problem. Dr Gaynor’s experience is similar
to the series from Toronto reported by Hashmi and the series
from Boston reported by Jenkins. In our experience, patients
treated more recently have an even worse prognosis than
those treated in the earlier era. 
Dr Gaynor’s group identified the following as risk factors:
abnormal pulmonary veins, thickening of the muscular walls,
increased elastin, and dilated lumen. Jenkins previously
reported that small pulmonary artery diameter and a small
pulmonary artery confluence are predictors of poor outcome. 
Is there hope for these children? Razzouk and associates,
from Loma Linda, reported on 30 children with heterotaxy
who had a 65% survival 5 years after heart transplantation.
Heterotaxy was not a risk factor among their transplant series. 
I have two questions for Dr Gaynor. First, is the histology
of dilated pulmonary veins that you report compatible with
the observations of Jenkins that small pulmonary veins are
detrimental to survival? 
Second, what is the current or future protocol at The
Children’s Hospital of Philadelphia for managing infants
with single ventricle and TAPVC in combination? If trans-
plantation is recommended, what priority do these children
warrant to procure a very scarce resource? 
Dr Gaynor. Dr Williams, thank you very much for your
comments. The pathology that we examined is of children
who have undergone repair of TAPVC, and they may have
had high atrial pressures. We examined small veins within the
lung parenchyma. Because this is a retrospective study, we
were unable to assess the size of the pulmonary veins at the
site of entrance into the heart to know how small or how large
those veins were. If there is obstruction at that level, the
upstream veins may be dilated. 
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In terms of the current management of the children at our
institution, certain children can be managed initially with
only an aortopulmonary shunt. The major group includes
children who have unobstructed pulmonary venous drainage,
particularly drainage to the cardiac veins or to the cavoatrial
junction. The mortality for shunt alone as the initial palliative
procedure was acceptable. We would probably use a shunt in
those children and then try to determine the optimal method
of treatment at a later date, either cavopulmonary anastomo-
sis leading to a Fontan operation or cardiac transplantation. 
For children who are brought for treatment in the neonatal
period and have pulmonary veins that must be repaired, par-
ticularly those with obstructed veins, cardiac transplantation
is the best option. I think the presence of either a systemic
shunt or a venous shunt in children who have these abnormal
pulmonary vessels and a high degree of reactivity is the rea-
son for the high mortality. 
Many of the infant hearts available for transplantation are
currently used for children with HLHS who do have another
option, the Norwood procedure. In these children with
TAPVC and single ventricle, there really is no other option. 
Under the current organ allocation system, infants are not
stratified as possible recipients for cardiac transplantation
according to the availability of other possible procedures. As
a group, we should amend that system to give priority to
infants for whom cardiac transplantation is the only option.
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